Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under 2 spellings of its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Allergy Laboratories with 1 drug recall and 1 device recall. The most recent is a drug recall dated Aug 10, 2016: Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill i….
| Aug 10, 2016 | Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Class II · Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially | Drug recalls |
| Feb 3, 2015 | GREER 2 ML Sterile Empty Vials 2-13 vial 25 ea - Silver CapClass II · Potential for glass particles within the vials | Device recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
